Product Information
METFORMIN HCL 850 MG TABLET is a generic product labeled by Legacy Pharmaceutical Packaging, LLC, priced at $0.0239 per EA under NDC 68645058359. Its NADAC has been published 331 times since Oct 9, 2019.
FDA first approved this application on Apr 22, 2010. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
850 mg/1
Manufacturer
Legacy Pharmaceutical Packaging, LLCNDC
68645058359
Classification
Generic
Dosage Form
TABLET
Route
ORAL
Effective Date
8/19/2026
Active Ingredients
METFORMIN HYDROCHLORIDEApproval Type
Generic (ANDA)
FDA Application
ANDA090564FDA Approved
4/22/2010
TE Code
AB
On Market Since
6/7/2019
Pharmacological Classes
Price Statistics
The NADAC for METFORMIN HCL 850 MG TABLET has been published 331 times since Oct 9, 2019, and over the history we have for it it has declined 19.2%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.0239 per EA |
|---|---|
| All-time high | $0.0312 (Nov 13, 2019) |
| All-time low | $0.0196 (May 22, 2024) |
| 52-week high | $0.0248 |
| 52-week low | $0.0224 |
| Median price | $0.0266 |
| Average price | $0.0262 |
| Largest weekly change | +26.0% (Jun 19, 2024) |
| Weeks tracked | 331 |
| Tracking since | Oct 9, 2019 |
Generic Alternatives
No other NADAC-published product shares this drug's active ingredient and strength in a comparable dosage form. Compare the broader picture on the Metformin hydrochloride market page.
Lowest-Cost Alternatives
No alternatives available
Related Drugs
Same classification
Frequently asked questions
What is the NADAC price of METFORMIN HCL 850 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for METFORMIN HCL 850 MG TABLET, manufactured by Legacy Pharmaceutical Packaging, LLC, is $0.0239 per EA (NDC 68645058359), effective Aug 19, 2026.
How has the price of METFORMIN HCL 850 MG TABLET changed over time?
Over the history we have for it, the NADAC for METFORMIN HCL 850 MG TABLET has declined 19.2%. It has been tracked across 331 weekly CMS publications since Oct 9, 2019.
What are the highest and lowest recorded NADAC prices for METFORMIN HCL 850 MG TABLET?
Since Oct 9, 2019, the NADAC for METFORMIN HCL 850 MG TABLET has ranged from a low of $0.0196 (May 22, 2024) to a high of $0.0312 (Nov 13, 2019), with a median of $0.0266 per EA.
Are there cheaper alternatives to METFORMIN HCL 850 MG TABLET?
No other NADAC-published product currently shares the active ingredient and strength of METFORMIN HCL 850 MG TABLET in a comparable dosage form, so no direct lower-cost alternative is listed.
Who manufactures METFORMIN HCL 850 MG TABLET?
METFORMIN HCL 850 MG TABLET (NDC 68645058359) is labeled by Legacy Pharmaceutical Packaging, LLC, and CMS classifies it as a generic product.